Observational Study - ILM Peeling

Macular Hole Clinical Trial

Official title:

Observational Study On Retinal Structure And Function Before And After Epimacular Membrane Peeling

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT01083056
• Other study ID #: ILM Peeling
• Status: Completed
• Phase: N/A
• First received: March 8, 2010
• Last updated: July 30, 2014
• Start date: March 2010
• Est. completion date: July 2014

Study information

• Verified date: July 2014
• Source: University Hospital Tuebingen
• Contact: n/a
• Is FDA regulated: No
• Health authority: Germany: Ministry of Health
• Study type: Observational

Clinical Trial Summary

This observational study investigates the effects of epimacular membrane peeling on the structure and function of the retina.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 10
• Est. completion date: July 2014
• Est. primary completion date: July 2014
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Clinical diagnosis of Epimacular Gliosis

• Must be scheduled for ILM-peeling independently of study

• Must be older then 18 years of age

Exclusion Criteria:

• Visual acuity > 0,4 logMAR (< 20/50 EDTRS)

• Other ophthalmological disorder affecting visual acuity and/or visual field and/or retinal structure

Study Design

Observational Model: Cohort, Time Perspective: Prospective

Related Conditions & MeSH terms

• Epimacular Gliosis
• Macular Hole

Locations

Country	Name	City	State
Germany	Centre for Ophthalmology, University Hospital Tuebingen	Tuebingen	BW

Sponsors (1)

Lead Sponsor	Collaborator
University Hospital Tuebingen

Country where clinical trial is conducted

Germany, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	BCVA		6 months after ILM peeling	No